ReverseScreen3D: A structure-based ligand matching method to identify protein targets

Journal of Chemical Information and Modeling

Volumn 51, Issue 3, 2011, Pages 624-634

  Kinnings, Sarah L ^a   Jackson, Richard M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DATABASE SYSTEMS; PROTEINS; QUERY PROCESSING;

BIOACTIVE CONFORMATION; GEOMETRIC MATCHING; MULTIPLE TARGETS; POTENTIAL PROTEINS; POTENTIAL TARGETS; PROTEIN INHIBITORS; STRUCTURAL COMPARISON; VIRTUAL SCREENING;

LIGANDS;

LIGAND; PROTEIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY;

LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEINS;

EID: 79953212647     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci1003174     Document Type: Article

References (42)

1. Li, H.; Gao, Z.; Kang, L.; Zhang, H.; Yang, K.; Yu, K.; Luo, X.; Zhu, W.; Chen, K.; Shen, J.; Wang, X.; Jiang, H. TarFisDock: A Web server for identifying drug targets with docking approach Nucleic Acids Res. 2006, 34 (Web Server issue) W219-24
2. Paul, N.; Kellenberger, E.; Bret, G.; Muller, P.; Rognan, D. Recovering the true targets of specific ligands by virtual screening of the protein data bank Proteins 2004, 54 (4) 671-680 (Pubitemid 38298786)
3. Gao, Z.; Li, H.; Zhang, H.; Liu, X.; Kang, L.; Luo, X.; Zhu, W.; Chen, K.; Wang, X.; Jiang, H. PDTD: A Web-accessible protein database for drug target identification BMC Bioinf. 2008, 9, 104
4. Chen, Y. Z.; Ung, C. Y. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach J. Mol. Graph. Modell. 2001, 20 (3) 199-218 (Pubitemid 33149732)
5. Zahler, S.; Tietze, S.; Totzke, F.; Kubbutat, M.; Meijer, L.; Vollmar, A. M.; Apostolakis, J. Inverse in silico screening for identification of kinase inhibitor targets Chem. Biol. 2007, 14 (11) 1207-1214 (Pubitemid 350102244)
6. Yildirim, M. A.; Goh, K. I.; Cusick, M. E.; Barabasi, A. L.; Vidal, M. Drug-target network Nat. Biotechnol. 2007, 25 (10) 1119-1126 (Pubitemid 47538114)
7. Paolini, G. V.; Shapland, R. H.; van Hoorn, W. P.; Mason, J. S.; Hopkins, A. L. Global mapping of pharmacological space Nat. Biotechnol. 2006, 24 (7) 805-815 (Pubitemid 44086621)
8. Weber, A.; Casini, A.; Heine, A.; Kuhn, D.; Supuran, C. T.; Scozzafava, A.; Klebe, G. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: New pharmacological opportunities due to related binding site recognition J. Med. Chem. 2004, 47 (3) 550-557 (Pubitemid 38129713)
9. Hopkins, A. L. Network pharmacology: The next paradigm in drug discovery Nat. Chem. Biol. 2008, 4 (11) 682-690
10. Xie, L.; Li, J.; Bourne, P. E. Drug discovery using chemical systems biology: Identification of the protein-ligand binding network to explain the side effects of CETP inhibitors PLoS Comput. Biol. 2009, 5 (5) e1000387
11. Xie, L.; Wang, J.; Bourne, P. E. In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators PLoS Comput. Biol. 2007, 3 (11) e217
12. Nobeli, I.; Favia, A. D.; Thornton, J. M. Protein promiscuity and its implications for biotechnology Nat. Biotechnol. 2009, 27 (2) 157-167
13. Chong, C. R.; Sullivan, D. J., Jr. New uses for old drugs Nature 2007, 448 (7154) 645-646 (Pubitemid 47236844)
14. DiMasi, J. A.; Hansen, R. W.; Grabowski, H. G. The price of innovation: New estimates of drug development costs J. Health. Econ. 2003, 22 (2) 151-185 (Pubitemid 36279392)
15. Cai, J.; Han, C.; Hu, T.; Zhang, J.; Wu, D.; Wang, F.; Liu, Y.; Ding, J.; Chen, K.; Yue, J.; Shen, X.; Jiang, H. Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: Reverse docking, enzymatic assay, and X-ray crystallography validation Protein Sci. 2006, 15 (9) 2071-2081 (Pubitemid 44316010)
16. Liu, X.; Ouyang, S.; Yu, B.; Liu, Y.; Huang, K.; Gong, J.; Zheng, S.; Li, Z.; Li, H.; Jiang, H. PharmMapper server: A Web server for potential drug target identification using pharmacophore mapping approach Nucleic Acids Res. 2010, 38 (Web Server issue) W609-W614
17. Muller, P.; Lena, G.; Boilard, E.; Bezzine, S.; Lambeau, G.; Guichard, G.; Rognan, D. In silico-guided target identification of a scaffold-focused library: 1,3,5-Triazepan-2,6-diones as novel phospholipase A2 inhibitors J. Med. Chem. 2006, 49 (23) 6768-6778 (Pubitemid 44749744)
18. Keiser, M. J.; Setola, V.; Irwin, J. J.; Laggner, C.; Abbas, A. I.; Hufeisen, S. J.; Jensen, N. H.; Kuijer, M. B.; Matos, R. C.; Tran, T. B.; Whaley, R.; Glennon, R. A.; Hert, J.; Thomas, K. L.; Edwards, D. D.; Shoichet, B. K.; Roth, B. L. Predicting new molecular targets for known drugs Nature 2009, 462 (7270) 175-181
19. Schuffenhauer, A.; Zimmermann, J.; Stoop, R.; van der Vyver, J. J.; Lecchini, S.; Jacoby, E. An ontology for pharmaceutical ligands and its application for in silico screening and library design J. Chem. Inf. Comput. Sci. 2002, 42 (4) 947-955 (Pubitemid 35355244)
20. Kinnings, S. L.; Jackson, R. M. LigMatch: A multiple structure-based ligand matching method for 3D virtual screening J. Chem. Inf. Model 2009, 49 (9) 2056-2066
21. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein data bank Nucleic Acids Res. 2000, 28 (1) 235-242 (Pubitemid 30047768)
22. Altschul, S. F.; Gish, W.; Miller, W.; Myers, E. W.; Lipman, D. J. Basic local alignment search tool J. Mol. Biol. 1990, 215 (3) 403-10
23. Hu, L.; Benson, M. L.; Smith, R. D.; Lerner, M. G.; Carlson, H. A. Binding MOAD (mother of all databases) Proteins 2005, 60 (3) 333-340 (Pubitemid 41061630)
24. Dessailly, B. H.; Lensink, M. F.; Orengo, C. A.; Wodak, S. J. LigASite: A database of biologically relevant binding sites in proteins with known apo-structures Nucleic Acids Res. 2008, 36 (Database issue) D667-D673
25. Strombergsson, H.; Kleywegt, G. J. A chemogenomics view on protein-ligand spaces BMC Bioinformatics 2009, 10 (Suppl 6) S13
26. th ed.; Lockwood, L.; McGahey, P., Eds.; Thomson Brooks/Cole: Canada, 2009; Vol. 2, p 387.
27. Brakoulias, A.; Jackson, R. M. Towards a structural classification of phosphate binding sites in protein-nucleotide complexes: an automated all-against-all structural comparison using geometric matching Proteins 2004, 56 (2) 250-260 (Pubitemid 38850159)
28. Dalton, J. A. R. The Homology Modelling of Protein-Ligand Interactions. Ph.D. Thesis, University of Leeds, 2009.
29. Kirchmair, J.; Wolber, G.; Laggner, C.; Langer, T. Comparative performance assessment of the conformational model generators omega and catalyst: A large-scale survey on the retrieval of protein-bound ligand conformations J. Chem. Inf. Model. 2006, 46 (4) 1848-1861 (Pubitemid 44185709)
30. The Open Babel Package, version 2.1.1. http://openbabel.org (accessed 07/05/ 2008).
31. Guha, R.; Howard, M. T.; Hutchison, G. R.; Murray-Rust, P.; Rzepa, H.; Steinbeck, C.; Wegner, J.; Willighagen, E. L. The Blue Obelisk-Interoperability in chemical informatics J. Chem. Inf. Model. 2006, 46 (3) 991-998
32. Wishart, D. S.; Knox, C.; Guo, A. C.; Shrivastava, S.; Hassanali, M.; Stothard, P.; Chang, Z.; Woolsey, J. DrugBank: A comprehensive resource for in silico drug discovery and exploration Nucleic Acids Res. 2006, 34 (Database issue) D668-D672
33. Favoni, R. E.; de Cupis, A. Steroidal and nonsteroidal oestrogen antagonists in breast cancer: basic and clinical appraisal Trends Pharmacol. Sci. 1998, 19 (10) 406-415 (Pubitemid 28515675)
34. Santner, S. J.; Santen, R. J. Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens J. Steroid Biochem. Mol. Biol. 1993, 45 (5) 383-390 (Pubitemid 23163015)
35. Levine, R. M.; Rubalcaba, E.; Lippman, M. E.; Cowan, K. H. Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line Cancer Res. 1985, 45 (4) 1644-1650 (Pubitemid 15079118)
36. Nuwaysir, E. F.; Daggett, D. A.; Jordan, V. C.; Pitot, H. C. Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen Cancer Res. 1996, 56 (16) 3704-3710 (Pubitemid 26272016)
37. Ritchie, G. A. The direct inhibition of prostaglandin synthetase of human breast cancer tumor tissue by tamoxifen Recent Results Cancer Res. 1980, 71, 96-101 (Pubitemid 10121386)
38. Abbas Abidi, S. M.; Howard, E. W.; Dmytryk, J. J.; Pento, J. T. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells Clin. Exp. Metastasis 1997, 15 (4) 432-439 (Pubitemid 27285817)
39. Lax, E. R.; Rumstadt, F.; Plasczyk, H.; Peetz, A.; Schriefers, H. Antagonistic action of estrogens, flutamide, and human growth hormone on androgen-induced changes in the activities of some enzymes of hepatic steroid metabolism in the rat Endocrinology 1983, 113 (3) 1043-1055 (Pubitemid 13051949)
40. Rowlands, M. G.; Budworth, J.; Jarman, M.; Hardcastle, I. R.; McCague, R.; Gescher, A. Comparison between inhibition of protein kinase C and antagonism of calmodulin by tamoxifen analogues Biochem. Pharmacol. 1995, 50 (5) 723-726
41. Messiha, F. S. Leu-enkephalin, tamoxifen and ethanol interactions: Effects on motility and hepatic ethanol metabolizing enzymes Gen. Pharmacol. 1990, 21 (1) 45-48 (Pubitemid 20037952)
42. Paavonen, T.; Aronen, H.; Pyrhonen, S.; Hajba, A.; Andersson, L. C. The effect of toremifene therapy on serum immunoglobulin levels in breast cancer APMIS 1991, 99 (9) 849-853